23 | CUMBERLAND PHARMACEUTICALS
WHAT IT DOES: Acquires specialty pharmaceutical products that are currently marketed or in late-stage development and grows them through marketing to underserved physician segments. HOW IT GREW:
Cumberland Pharmaceuticals has grown by providing high-quality medicine that addresses unmet medical needs, officials say. Cumberland’s focus is hospital acute-care gastroenterology, a segment to which it provides three pharmaceutical products. Last year, the company added its fourth medication, Hepatoren, which Cumberland is currently testing and developing. According to the company’s quarterly report filed Aug. 9, Cumberland’s continued growth is based on maximizing the potential of existing products while adding new, differentiated medicines. Specifically, the company is focused on comprehensive marketing and promotional campaigns in the U.S. and expanding its operations to select international markets, such as Australia and Canada. Cumberland is looking into expanding the use of its existing drugs by seeking out new data and product indications.